Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative study to examine the effects of changing between thienopyridine drugs on platelet aggregation activity for patients who are consistently treated with dual antiplatelet therapy: DAPT (clopidogrel + aspirin) over 52 weeks

Trial Profile

Comparative study to examine the effects of changing between thienopyridine drugs on platelet aggregation activity for patients who are consistently treated with dual antiplatelet therapy: DAPT (clopidogrel + aspirin) over 52 weeks

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 20 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms CONVERT 2
  • Most Recent Events

    • 25 Oct 2018 Status changed from recruiting to completed.
    • 29 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 11 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top